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 Most people have only a few key questions regarding 
risk（s） associated with a past or possible future 
exposure to a potentially harmful substance. Foremost 
is the deceptively simple question: what is my risk?  
Other important issues are: How certain are you of the 
risk-estimate you are telling me?  How does this risk 
compare to other risks in my life?  Is my risk voluntary 
or involuntary?  and What are my alternatives?  People 
need this information for many reasons but especially for 
informed decision-making. 
 Effective communication of the risk of cancer in 
persons exposed to ionizing radiation is challenging. 
Conventional approaches of presenting cancer-risks are 
indirect and are typically point-estimates relying on units 
of dose or concentrations of a radioactive substance in the 
environment. Information given in this fashion is unlikely 
to inform most people; worse, it can be misleading. 
Communication of the potential health consequences 
of radiation exposure using units of dose also fails to 
consider that radiation-related cancer risk is highly-
dependent on the age at time of exposure remaining 
life-span, exposure to other cancer-causing agents （like 
smoking）, co-morbid conditions and other variables not 
encompassed in the expression of dose. 
 The fundamental problem with relying on dose to 
express cancer-risk is that dose is only an intermediate 
quantity between exposure and risk. When dose is used 
to express risk it is typically compared with radiation 
benchmarks like regulatory dose-limits （ICRP, US 
EPA, NRC）, doses associated with natural background 
radiations, doses from exposure to medical procedures 
（X-rays, CT-scans, radioisotope studies） and/or doses at 
the limits of a statistically significant detection of cancer 
risks observed in epidemiologic studies, like the Japanese 
A-bomb survivors. The implication is that if the estimated 
dose is below dose or concentration values used for these 
comparisons, there should be no cause for concern and 
that the risk at these dose levels is acceptable. 
 The limitations of using an estimate of dose or a level 
of radioactivity exposure or concentration as a surrogate 
for estimating risk are obvious, but is there a better way 
to express potential cancer-related hazards of radiation 
exposures to people?
 Yes. Here are some alternatives: （1） total lifetime 
risk of cancer incidence （and/or cancer-related death） 
regardless of cause; （2） excess lifetime risk resulting 
only from additional （above baseline） radiation exposure; 
（3） future total and/or excess lifetime cancer-risk for 
persons exposed in the past （or who will be exposed 
soon） and who are currently free of cancer （radiation-
related or not）; and （4） total and/or excess numbers of 
cancers anticipated in an exposed population over their 
lifetime. For persons previously-exposed to radiation 
who develop a potentially radiation-related cancer, risk 
can be translated into a person-specific assigned share 
sometimes called probability of causation. 
 All of these risk-estimates （and others） need to 
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be quantified with regard to uncertainty which arises 
from several sources including: （1） uncertainty in 
subject-specific absorbed dose-estimates to each organ; 
（2） uncertainty in extrapolating dose-estimates into 
a risk-estimate to the individual or to a population; 
（3） statistical uncertainty in risk coefficients from 
epidemiological studies, like of the A-bomb survivors, 
for specific cancer-sites; （4） uncertainty in the model 
used to transfer risk-estimates from that seen in the 
A-bomb survivors to the US population for diseases 
with markedly-different baseline rates between the two 
populations （for example, breast and gastric cancers）; 
（5） uncertainty in the model and coefficients used to 
extrapolate the dose-response observed at high doses and 
high dose-rates seen in the A-bomb survivors to settings 
where doses are lower and where exposure is prolonged 
over time and associated with either fractionated 
or chronic low-dose rates; and （6） uncertainty in 
extrapolating risks observed from the A-bomb survivors 
who were exposed primarily to an acute, high-energy 
gamma radiation to other types of radiation-exposures 
including alpha particles, neutrons, low energy beta 
particles （like tritium） and low energy photons （like 
X-rays）. 
 Effective communication of cancer-risk to the 
public also requires a vital but volatile quantity: trust. 
Communicating cancer-risk assessments to people by 
dose-estimates and benchmarks without addressing 
the fundamental issue of cancer-risk associated with 
exposure may lead to a perception of censorship of risk 
information. Such perceptions of censorship diminish 
trust, which, once lost, is difficult if not impossible to 
regain. 
 People have bona fide concerns about radiation-
related cancer-risks and deserve direct, credible and 
intelligible answers. Information about risk should 
include uncertainty in risk-estimates that reflect 
current knowledge. We believe communication of a 
95% uncertainty range or credibility interval is more 
informative than a single best estimate point-value. The 
upper limit of a 95% uncertainty range indicates of how 
high the risk might be whereas the lower limit represents 
a lower bound estimate of risk. If the upper limit is below 
a level of risk judged to be acceptable, the exposure may 
be regarded as low-priority and no action may be needed. 
However, if the lower limit is above a level of risk judged 
to be unacceptable, the exposure may be regarded as 
high-priority and may precipitate some form of action 
to reduce or eliminate exposure or even direct medical 
intervention. 
 Some scientists argue there is a threshold in the dose-
response relationship of radiation-exposure to cancer-
risk such that there is no risk below a certain dose 
（usually somewhere between 50-200 mSv）. However, 
the weight of evidence supporting this assumption is 
weak. Furthermore, even if the potential for a threshold 
effect were taken into account in cancer-risk estimation, 
this effect will have its’ greatest influence on the lower 
bound of a 95% uncertainty interval and only a minor 
influence on the upper bound estimate of risk. This is 
important because it is the upper bound of uncertainty in the 
estimate of cancer-risk that most concerns the public and 
which has the greatest implication for health protection. 
Moreover, arguing for a threshold-effect at low doses 
is difficult without a cogent biological explanation and 
without convincing evidence that exposure to background 
radiation is completely risk-free. As long as background 
radiation is assumed to be associated with some level of 
cancer-risk, any additional exposure to ionizing radiations, 
no matter how small, will increase the unavoidable risk 
associated with background radiation. Finally, arguing 
for a threshold effect, and therefore a radiation-dose 
associated with no cancer-risk, is likely to result in an 
erosion of public trust and should thus only be done when 
there is incontrovertible evidence to support this view. We 
think this level of evidence is lacking presently［1］. 
 Cancer-risks of radiation-exposure should be 
estimated and communicated effectively. The challenge is 
to place this risk into context such that it can be compared 
to voluntary and involuntary cancer-risks in everyday life 
（naturally-occurring and environmental）. Placing risk-
estimates into context helps people weigh the importance 
of a cancer-risk and decide whether a future exposure is 
acceptable. Equally important is the ability to compare 
cancer-risk （and uncertainty） with potential alternatives 
and with potential benefits （like having a CT-scan）. 
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 Information regarding the magnitude of a radiation-
related cancer-risk to other risks is important when 
communicating with the public. One useful approach is 
graphical comparisons in the form of risk-thermometers. 
Examples are Figure 1 where we compare cancer-risks 
of different radiation-exposures and Figure 2 where we 
compare cancer-risks of diverse involuntary exposures. 
 Other issues the public wants and needs to know to 
make informed decisions is not just the cancer-risk of 
radiation-exposure but: What type（s） of cancer we are 
talking about?  How common is this type of cancer absent 
radiation-exposure?  At what age is the cancer likely to 
occur?  and What is my prognosis if I get a radiation-
related cancer?  Consider, for example, non-melanoma 
skin cancers, thyroid cancer and lung cancer all of which 
are radiation-related cancers. Non-melanoma skin cancers 
are common without exposure to ionizing radiation, 
easily-treated and unlikely to be fatal. Getting one, 
especially at an older age, is unlikely to be extraordinarily 
upsetting to most people. Thyroid cancer is less common 
absent radiation-exposure, may require more extensive 
therapy, but is also unlikely to be fatal. Finally, lung 
cancer is relatively common like non-melanoma skin 
cancers, but therapy （if given） is most unpleasant, and 
survival after diagnosis is typically less than 6 months. 
The perception of the risk of lung cancer risk is also 
likely perceived differently by a young non-smoker than 
by an older person who has smoked most of his or her 
life. When we communicate radiation-related cancer-
risk to the public we typically overlook these important 
considerations. Ways to improve on this situation are 
complex and continually being developed. 
 In summary, we believe direct assessment of cancer-
risk from radiation-exposure including an expression of 
uncertainty rather than indirect assessment of cancer-
risk using dose or the environmental concentration of 
a radioactive substance is more useful to informing the 
public of the potential importance of past, present or 
future radiation-exposures. It is especially important to 
acknowledge that the uncertainty in our risk estimates is 
based on our present knowledge and that this uncertainty 
may change as our state of knowledge improves. This 
approach will better inform the public and allow for more 
intelligent decision-making. It will also help build trust 
between scientists and the public, a step essential for 
effective communication. 
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Fig. 1 Lifetime cancer-risk from exposure to radiation. 
Original version with references at: www.senes.
com/BeyondDoseAssessment/figure.1.htm. Indoor 
radon levels of 46 Bq me-3; NTS fallout data 
assume a female born in 1952 receiving a thyroid 
dose of 0.1 Gy; CT scan in a 50 year old female; 
negligible dose is 10 μSv ye-1 with a 70 y chronic 
exposure. 
Fig. 2 Involuntary lifetime cancer-risk for several 
carcinogenic substances. Original color 
version and references at www.senes.com/
BeyondDoseAsses smen t / f igu re .2 . h tm. 
www.senes.com/BeyondDoseAssessment/
figure.1.htm. Air levels refer to outdoor air in 
California. 
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Footnote
1 ） We recognize many epidemiological studies show no 
statistically-significant excess risk for cohorts exposed 
to high levels of background radiation （excluding the 
statistically-significant increased risk of lung cancer 
observed in epidemiological studies on residential 
exposures to radon decay products）. However, these high 
background exposure studies cannot be used as direct 
evidence of the absence of cancer-risk without supporting 
mechanistic explanations. Precautionary interpretation 
of these studies, for purposes of health protection, is 
that cancer-risk associated with exposure to background 
radiation has not been detected at a high-level of statistical 
confidence even though the underlying cancer-risk is 
present. Evidence supporting the absence of exposure-
related cancer-risk at or near background dose levels 
should be considered when estimating the uncertainty in 
risk when exposures are below limits of epidemiological 
detection. 
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